Details for New Drug Application (NDA): 216557
✉ Email this page to a colleague
The generic ingredient in ISOSORBIDE MONONITRATE is isosorbide mononitrate. There are thirty-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the isosorbide mononitrate profile page.
Summary for 216557
Tradename: | ISOSORBIDE MONONITRATE |
Applicant: | Aurobindo Pharma |
Ingredient: | isosorbide mononitrate |
Patents: | 0 |
Pharmacology for NDA: 216557
Physiological Effect | Vasodilation |
Suppliers and Packaging for NDA: 216557
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ISOSORBIDE MONONITRATE | isosorbide mononitrate | TABLET, EXTENDED RELEASE;ORAL | 216557 | ANDA | A-S Medication Solutions | 50090-6661 | 50090-6661-0 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6661-0) |
ISOSORBIDE MONONITRATE | isosorbide mononitrate | TABLET, EXTENDED RELEASE;ORAL | 216557 | ANDA | A-S Medication Solutions | 50090-6661 | 50090-6661-1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6661-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 30MG | ||||
Approval Date: | Nov 7, 2022 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 60MG | ||||
Approval Date: | Nov 7, 2022 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 120MG | ||||
Approval Date: | Nov 7, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription